GlassScriptPhysician profile
Corinne Tuckey-Larus
NPI 1861464695
$2,698.85
in general payments reported to CMS, 2019-2025
31 companies · $638 in 2025
The $638 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $40.07 · 2021: $208 · 2022: $308 · 2023: $431 · 2024: $431 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $114 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,296.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $113.99 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $416.48 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $358.58 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $277.17 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $271.95 | 2019-2023 | Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $183.66 | 2022-2024 | Aptima |
| Biogen, INC. | $177.37 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $143.51 | 2019-2025 | |
| Avion Pharmaceuticals | $117.63 | 2019 | |
| Coopersurgical, INC. | $89.63 | 2019-2025 | Paragard T 380a |
| Conmed Corporation | $66.67 | 2019 | |
| Allergan, INC. | $61.71 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.51 | 2021-2025 | |
| Myovant Sciences INC. | $59.39 | 2021-2022 | |
| Optumhealth Care Solutions, LLC | $51.54 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Caldera Medical, INC | $48.09 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32.68 | 2024 | V-Loc 180, Ligasure |
| Exeltis, USA INC. | $31.68 | 2019-2021 | |
| Daiichi Sankyo INC. | $30.58 | 2024 | Injectafer |
| Therapeuticsmd, INC. | $29.78 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $22.07 | 2023 | |
| Becton, Dickinson and Company | $19.05 | 2025 | Bd Max System, Bd Max Instrument |
| Minerva Surgical, INC | $18.72 | 2025 | |
| Terumo Medical Corporation | $18.49 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.08 | 2022 | |
| Organon LLC | $16.65 | 2025 | Nexplanon |
| Intuitive Surgical, INC. | $15.92 | 2019 | |
| Sanofi Pasteur INC. | $15.08 | 2025 | |
| Amag Pharmaceuticals, INC. | $13.59 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.36 | 2019 | |
| Amgen INC. | $11.41 | 2021 | |
| Meditrina | $9.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinne Tuckey-Larus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.